CEO: | Anders Lundstrom |
Independent Non-Executive Director: | Fabiana Lacerca Allen |
Independent Non-Executive Director: | Peter Llewellyn-Davies |
Non-Executive Chairman: | Hans-Peter Hasler |
Non-Executive Dir: | Christian Schweiger |
Address: | Northern Design Centre, Baltic Business Quarter, Gateshead Quays, United Kingdom, NE8 3DF |
Phone: | +44 (0) 191 511 8500 |
Website: | http://www.shieldtherapeutics.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BYV81293 |
Currency | UK Pounds |
Share Price | 2.35p |
Change Today | -0.050p |
% Change | -2.08 % |
52 Week High | 5.34 |
52 Week Low | 1.60 |
Volume | 705,058 |
Shares Issued | 1,041.69m |
Market Cap | £24.48m |
Beta | 0.02 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
15:41 | 330,194 @ 2.42p |
14:12 | 5,000 @ 2.42p |
12:44 | 1,051 @ 2.35p |
12:44 | 41,288 @ 2.42p |
11:47 | 250,000 @ 2.40p |
You are here: research